These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
3. [Dementing disorders. What benefits do the new anti-dementia drugs have?]. Ihl R MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Alzheimer disease. Winslow BT; Onysko MK; Stob CM; Hazlewood KA Am Fam Physician; 2011 Jun; 83(12):1403-12. PubMed ID: 21671540 [TBL] [Abstract][Full Text] [Related]
5. [Modern therapy for dementia]. Padberg F; Möller HJ; Bottlender R; Hampel H MMW Fortschr Med; 2005 May; 147 Spec No 2():71-4, 76-7. PubMed ID: 15968877 [TBL] [Abstract][Full Text] [Related]
6. [Cholesterol inhibitor and memantine in symptomatic dementia therapy]. Rodda J; Carter J Praxis (Bern 1994); 2013 Feb; 102(5):293-300; discussion 298-9. PubMed ID: 23446240 [No Abstract] [Full Text] [Related]
7. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias. Masterman D Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487 [No Abstract] [Full Text] [Related]
8. [Current antidementive therapy]. Perneczky R; Kurz A MMW Fortschr Med; 2004 May; 146 Spec No 2():53-6. PubMed ID: 15376702 [TBL] [Abstract][Full Text] [Related]
9. [Alzheimer drugs for mild cognitive impairment]. Fellgiebel A Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of degenerative dementia disorders--who should be treated?]. Hasselbalch SG; Kampmann JP Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606 [TBL] [Abstract][Full Text] [Related]
11. [Consensus statement "Dementia 2010" of the Austrian Alzheimer Society]. Schmidt R; Marksteiner M; Dal-Bianco P; Ransmayr G; Bancher C; Benke T; Wancata J; Fischer P; Leblhuber CF; Psota G; Ackerl M; Alf C; Berek K; Croy A; Delazer M; Fasching P; Frühwald T; Fruhwürth G; Fuchs-Nieder B; Gatterer G; Grossmann J; Hinterhuber H; Iglseder B; Imarhiagbe D; Jagsch C; Jellinger K; Kalousek M; Kapeller P; Ladurner G; Lampl C; Lechner A; Lingg A; Nakajima T; Rainer M; Reisecker F; Spatt J; Walch T; Uranüs M; Walter A Neuropsychiatr; 2010; 24(2):67-87. PubMed ID: 20605003 [TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease. Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693 [TBL] [Abstract][Full Text] [Related]
15. How do we treat people with dementia in Croatia. Mimica N; Presecki P Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784 [TBL] [Abstract][Full Text] [Related]
16. Current pharmacotherapy for Alzheimer's disease. Lleó A; Greenberg SM; Growdon JH Annu Rev Med; 2006; 57():513-33. PubMed ID: 16409164 [TBL] [Abstract][Full Text] [Related]
17. Use of memantine for the treatment of dementia. Lo D; Grossberg GT Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine. Desmidt T; Hommet C; Camus V Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011 [TBL] [Abstract][Full Text] [Related]
19. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. O'Brien JT; Holmes C; Jones M; Jones R; Livingston G; McKeith I; Mittler P; Passmore P; Ritchie C; Robinson L; Sampson EL; Taylor JP; Thomas A; Burns A J Psychopharmacol; 2017 Feb; 31(2):147-168. PubMed ID: 28103749 [TBL] [Abstract][Full Text] [Related]